Multiomics prediction and immunogenic validation of personalized neoantigens in cholangiocarcinoma patients

Baoluhe Zhang, Bao Jin, Xueshuai Wan, Xiao Liu, Xiang’an Wu, Jiali Xing, Yuxin Wang, Haifeng Xu, Yiyao Xu, Mei Guan, Yilei Mao, Yating Bai, Junqi Zhu, Qian Chen, Shunda Du · 2026

Read Multiomics prediction and immunogenic validation of personalized neoantigens in cholangiocarcinoma patients by Baoluhe Zhang, Bao Jin, Xueshuai Wan, Xiao Liu, Xiang’an Wu, Jiali Xing, Yuxin Wang, Haifeng Xu, Yiyao Xu, Mei Guan, Yilei Mao, Yating Bai, Junqi Zhu, Qian Chen, Shunda Du (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13523427.txt.

Description

Baoluhe Zhang and a large team hunt for personalized neoantigens in bile duct cancer in a 2026 multiomics study. Neoantigens are altered protein fragments unique to a tumor that can train the immune system. Paired tumor and normal samples from thirty-three patients underwent DNA and RNA sequencing to map mutations and candidate neoantigens, and selected peptides were synthesized and tested for immune activation.

The familiar cancer gene TP53 was the most frequently mutated, and higher mutation counts tracked higher neoantigen loads. Nearly eight hundred neoantigens were identified across twenty-two samples. Sixteen peptides from three patients triggered strong T cell responses in laboratory tests, with the most potent coming from three named genes. Predicted receptor sequences for those responses were also reported. The authors frame the work as proof of concept for personalized immunotherapy in this hard-to-treat cancer.

Catalog record

CREATORBaoluhe Zhang, Bao Jin, Xueshuai Wan, Xiao Liu, Xiang’an Wu, Jiali Xing, Yuxin Wang, Haifeng Xu, Yiyao Xu, Mei Guan, Yilei Mao, Yating Bai, Junqi Zhu, Qian Chen, Shunda Du
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46657
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13523427

Browse the full library · About the Tower of Babel